["H]flunitrazepam after ultraviolet irradiation of the purified receptor. The persistent association of GABA, benzodiazepine, and chloride recognition sites after extensive purification suggests that they may be part of a single macromolecular complex.
Pharmacological evidence suggests that benzodiazepines exert their therapeutic effects by facilitating synaptic actions of 'yaminobutyric acid (GABA) (1-3). These observations have been substantiated by biochemical studies which show that GABA and related agents enhance the specific binding of benzodiazepines to receptor sites (4) (5) (6) (7) (8) . GABA receptors labeled specifically by [3H]GABA or [3H]muscimol (a rigid GABA analog) are not affected directly by benzodiazepines which neither increase nor decrease receptor binding (9) . However, [3H]muscimol-labeled GABA receptors do possess benzodiazepine recognition sites because benzodiazepines protect these GABA receptors from inactivation by heat and protein-modifying reagents (9) . Similarly, GABA as well as benzodiazepines protect benzodiazepine receptors from heat inactivation (9) . The existence of both GABA and benzodiazepine recognition sites on the two receptors suggests that GABA and benzodiazepine receptors might form a single macromolecular complex.
This possibility is favored by findings that, when benzodiazepine receptors are solubilized with 1% Triton (10, 11) , GABA stimulation of benzodiazepine binding is retained (11) whereas if GABA and benzodiazepine binding proteins were separate they might be expected to dissociate upon membrane solubilization. GABA and benzodiazepine recognition sites might be part of a macromolecular complex that can be dissociated by some but not other detergents as suggested by differential effects of Lubrol (12) and varying Triton concentrations on GABA stimulation of solubilized benzodiazepine receptors (13) . If they are fully distinct proteins, benzodiazepine and GABA receptors should dissociate during the course of purification.
In the present paper we report purification, by various Methods. Fresh calf brains (with the cerebellum removed) were homogenized with a Waring Blendor in 10 vol of 0.05 M Tris HCl (pH 7.4) and centrifuged at 50,000 X g for 15 min. Pellets were resuspended in 2 vol of the homogenizing buffer and frozen for 18 hr. The homogenate was thawed and washed five times by resuspension and centrifugation and frozen for 18 hr. After thawing, the pellet was extracted in 20 vol of 0.05 M Tris citrate (pH 7.4 at 4°C) containing 1% Triton X-100 for 10 min at 4°C and centrifuged at 100,000 X g for 90 min. The supernatant was used as a crude solubilized receptor extract.
Soluble receptor extract was gel filtered on a Sepharose 6-B column (2.5 x 80 cm) and eluted with 0.05 M Tris citrate (pH 7.4) containing 0.2% Triton X-100. Alternatively, receptor extract was applied to a DEAE-cellulose column (1.5 X 20 cm) and washed with 5 mM Tris citrate (pH 7.1) containing 0.2% Triton X-100. The column was eluted with a linear gradient (5-500 mM) of NaCl in the same buffer. Soluble extract prepared in 5 mM K phosphate, pH 7.4/0.2% Triton X-100 was applied to a hydroxylapatite column (1.5 x 15 cm) and eluted with a linear gradient (5-500 mM) of K phosphate containing 0.2% Triton X-100. Concanavalin A-Sepharose columns (1.5 x 13 cm) received receptor extract in 0.05 M Tris citrate, pH 7.1/0.2% Triton X-100 containing MnCl2, MgCl2, and CaCl2 as below and were eluted with 0.5 M a-methyl mannoside in Tris citrate containing 1 mM MnC12, 1 mM MgCl2, 1 mM CaC12, and 0.2% Triton X-100.
The affinity gel was prepared by coupling a benzodiazepine (Ro 7-1986/1) to cyanogen bromide-activated Sepharose 4B through a 7-carbon side arm. Soluble receptor was applied to the column in 0.05 M Tris citrate, pH 7.1/0.2% Triton X-100 and washed with 1000 ml of Tris citrate containing 0.2% Triton X-100. The column was eluted with 200 ml of HCI at pH 3.5 Abbreviation: GABA, y-aminobutyric acid. * Present address: Department of Pharmacology, Faculty of Medicine, Technion, Haifa, Israel.
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and quenched immediately in 20 ml of 0.5 M Tris citrate (pH 7.1). Sodium dodecyl sulfate/polyacrylamide gel electrophoresis was performed in slabs according to Laemmli (14) . Photoaffinity labeling of purified benzodiazepine receptor was.performed;as described by Mohler et al. (15) . Receptor was exposed to an ultraviolet lamp for 7 min and dialyzed four times against 1000 ml of H20. Receptor binding was assayed as before (10, 11) . (16) . In crude membrane homogenates, photoaffinity labeling with [3H]flunitrazepam appears to involve two or three proteins (17) . However, in these crude preparations, apparent differences in molecular weight in gel electrophoresis might merely reflect modifications in the mobility of a single protein produced by various tissue constituents.
RESULTS
Benzodiazepine receptors purified by affinity chromatography and photoactivated after labeling. with [3H]flunitrazepam displayed two discrete protein bands with molecular weights of 55,000 and 62,000 (Fig. 1) (Table 2) . Similarly, the potencies and selectivities of drugs at [3H]flunitrazepam sites were essentially the same with, the affinity chromatography-purified receptor as in the crude solubilized and membrane-bound receptors.
GABAergic and Chloride Regulation of Purified Benzodiazepine Receptors. Our earlier finding that GABA enhances benzodiazepine binding in soluble as well as in membranebound receptors-suggests that GABA recognition sites occur on the same protein as that which binds benzodiazepines (11) . However, it is conceivable that two completely separate GABAand benzodiazepine-recognizing proteins could continue to 10. manifest loose interactions even after solubilization from membranes. Extensive purification should dissociate such interactions. Accordingly, we examined the influence of GABA, 13-guanidinopropionic acid (an amino acid with GABA-like neurophysiologic actions), and diaminobutyric acid (a GABA analog which lacks GABA-like effects) ( Table 3) . Stimulation of benzodiazepine binding occurred with a similar potency and a similar maximal extent for GABA and ,B-guanidinopropionic acid in -membranes, in solubilized receptors, and in receptors pu- (23) (24) (25) . Increases.in chloride permeability are --associated with the synaptic actions of GABA. Chloride ion decreases GABA receptor binding (26) and enhances benzodiazepine binding in membranes (27) . If these influences reflect an association with the chloride conductance channel, it would be of interest to determine whether such effects are retained in solubilized and purified receptors. Accordingly, we evaluated the influence of chloride on membrane-bound, solubilized, and affinity chromatography-purified benzodiazepine receptors. In all three conditions, 50 mM NaCl or NaBr elicited about a 15% increase in [3H]flunitrazepam binding, resembling results with membrane bound receptors (27) .
DISCUSSION
A major finding of the present study is that GABA receptors labeled by [3H]muscimol and benzodiazepine receptors demonstrate similar enrichments after various purification procedures. This finding strongly suggests that the two receptor proteins are closely related or are.part of the same macromolecular complex and fits with evidence that each of the two receptors has both GABA and benzodiazepine recognition sites (9) . The similar enrichment in binding activity of the two receptors after affinity chromatography could result from two distinct proteins having benzodiazepine recognition sites. However, this would not explain the copurification of the two receptors by the four other purification procedures.
Are the GABA receptors labeled by [3H]muscimol the same as or different from the GABA recognition sites on benzodiazepine receptors? Initial studies of drug specificity suggested that these represent different sites (18) (19) (20) 
